Hongbo Lu insider trades

Open-market stock purchases and sales by Hongbo Lu, Director at Zenas BioPharma, Inc, from SEC Form 4 filings since Feb 19, 2019.

Track record: 100% of 9 scored buys are up 5% or more since purchase, averaging +70%.

Recent trades

DateStockTradeValue
Jun 15, 2026ZBIO Zenas BioPharma, IncBought (not open market)—
May 12, 2026ARWR Arrowhead Pharmaceuticals, IncSold$228K
Mar 31, 2026ZBIO Zenas BioPharma, IncBought$1.5M
Mar 31, 2026ZBIO Zenas BioPharma, IncBought$70.2K
Feb 11, 2026ZBIO Zenas BioPharma, IncBought$585K
Dec 16, 2025ARWR Arrowhead Pharmaceuticals, IncBought (not open market)—

Companies traded

  • ZBIO Zenas BioPharma, Inc: 6 buys, last Jun 15, 2026
  • ARWR Arrowhead Pharmaceuticals, Inc: 3 buys, 1 sale, last May 12, 2026
  • TERN Terns Pharmaceuticals, Inc: 7 buys, last Jun 11, 2025
  • AVDR Avedro Inc: other filings, last Nov 21, 2019
  • TPTX Turning Point Therapeutics, Inc: 1 buy, last Apr 22, 2019

Get free alerts when Hongbo Lu files a new trade →